Welcure Drugs & Pharmaceuticals Ltd

NSE: WELCURE · BSE: 524661 · Pharmaceuticals & Biotechnology · 7 announcements

Share price: ₹0.20
Market cap: ₹24.72 Cr
Revenue (annual): ₹365.5 Cr
Net profit (annual): ₹-5.49 Cr
P/E (TTM): -1.4×Sector 47.3×
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Financial Results 2 Debt & Borrowing 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

29 May 2026 20:01 IST BSE

Financial Results

Welcure Drugs & Pharmaceuticals Q4 FY26 Results: Net Loss of ₹49.9 Cr

Welcure Drugs & Pharmaceuticals Ltd reported a net loss of ₹49.9 Cr for Q4 FY26.

Key figure: Net loss ₹49.9 Cr

Open full results → Read the filing ↗

29 May 2026 20:00 IST BSE

Financial Results

Welcure Drugs & Pharmaceuticals Financial Results

Welcure Drugs and Pharmaceuticals reported annual total income of ₹367.00 Crore for FY26. The Board approved audited results, showing a net annual loss of ₹5.49 Crore.

Value: ₹367.0 Cr

Read the filing ↗